Impact Factor
2.77
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.59
285 total citations
h5-index
18
h5 depth signal
Cited share
58.8%
117 of 199
Total citations
285
Citation footprint
Metric signal
1.39
External metric anchor
Self-citation
22.8%
65 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
296
Iran
89
Indonesia
69
United States
68
Japan
36
Citing Fields of Research
Mycobacterial Diseases
1,097
Bacteriology
113
Lung Cancer
27
Antibiotic & Antibacterial Agents
24
Auto-Inflammatory Disorders
19
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,678
Articles tracked across the journal lifetime
Indexed publication set
199
117 cited publications
Last 12 months
124
20.7 publications/month
Open access share
100.0%
124 OA publications in the last year
Leading citing country
India
296 citing publications
Leading citing field
Mycobacterial Diseases
1,097 citing publications
Latest tracked publication
1 July 2026
10 recent records available
Coverage & Indexing History
v4n1, Mar. 2015-
v4n1, Mar. 2015- ; Selected citations only before this date
Research Focus & Classification
Indexed Subjects
Mycobacterial Diseases
Issuing & Sponsoring Bodies
issuing body
Asian-African Society of Mycobacteriology
Broad Categories
Bacteriology
Communicable Diseases
Mycobacterial Diseases
MeSH Descriptors
Mycobacterium Infections
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.4103/ijmy.ijmy_164_26
Open DOI
Outcomes of Pulmonary Tuberculoma Following Standard Antituberculosis Therapy: An Observational Study
Background: Tuberculosis (TB) in Indonesia causes a high burden, with pulmonary tuberculoma representing a mass-like manifestation that poses diagnostic and therapeutic challenges due to poor drug penetration. Data regarding the treatmen...
02
DOI 10.4103/ijmy.ijmy_120_26
Open DOI
Survival-based Prognostic Factors for Mortality in Drug-resistant Tuberculosis: A Systematic Review and Meta-analysis
Mortality among patients with drug-resistant tuberculosis (DR-TB) remains substantial despite advances in diagnosis and treatment. Individual studies have reported multiple prognostic factors for death, but findings remain heterogeneous....
03
DOI 10.4103/ijmy.ijmy_163_26
Open DOI
Negative Predictive Value of First-line Anti-tuberculosis Drug Patch Test in Delayed-type Hypersensitivity with Cutaneous Manifestations: The Role of Application Timing
Background: Tuberculosis (TB) remains a significant global health burden, particularly in Indonesia, which ranks second worldwide for TB cases. Hypersensitivity reactions to first-line anti-TB drugs (ATDs) often lead to treatment interru...
04
DOI 10.4103/ijmy.ijmy_115_26
Open DOI
A Rare Case Report: Mycobacterium abscessus in Central Nervous System Infections in Astrocytoma Patient
Mycobacterium abscessus (MAB), a rapid growing nontuberculous mycobacterium (NTM), is an emerging pathogen mostly associated with pulmonary disease, while central nervous system (CNS) involvement remains rare and has a poor prognosis. We...
05
DOI 10.4103/ijmy.ijmy_145_26
Open DOI
Differential Expression and Correlation of High-mobility Group Box 1 and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid across Leprosy Clinical Groups and Healthy Controls: A Cross-sectional Study
Background: Erythema nodosum leprosum (ENL) is an acute inflammatory complication of multibacillary leprosy. High-mobility group box 1 (HMGB1) mediates inflammatory signaling, whereas vascular endothelial growth factor (VEGF) regulates a...
06
DOI 10.4103/ijmy.ijmy_102_26
Open DOI
Highly- and Low-virulent Mycobacterium tuberculosis Strains of the Beijing Genotype Elicit Contrasting Immune Response in C57BL/6 Mice as Revealed by Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-alpha Distinct Expression
Background: The progression of tuberculosis (TB) to active disease is heavily influenced by innate immunity. Mycobacterium tuberculosis can alter host molecular pathways, compromising immune responses and facilitating infection. We aimed...
07
DOI 10.4103/ijmy.ijmy_105_26
Open DOI
Primary Drug Resistance Analysis of Mycobacterium tuberculosis in Liupanshui, China
Background: Drug-resistant tuberculosis (DR-TB) remains a major global public health challenge, while local drug resistance data in southwestern China are still incomplete. The drug resistance characteristics of Mycobacterium tuberculosi...
08
DOI 10.4103/ijmy.ijmy_146_26
Open DOI
Clinical Determinants of Early Structural Lung Damage Following Intensive Tuberculosis Therapy: A Prospective Cohort Study
Background: Post-tuberculosis lung disease (PTLD) is an important cause of persistent respiratory morbidity, yet clinical factors associated with structural lung abnormalities during anti-tuberculosis treatment remain poorly understood. ...
09
DOI 10.4103/ijmy.ijmy_94_26
Open DOI
Telomere Length Profile and Associated Clinical Factors among Tuberculosis Patients in Indonesia
Background: Tuberculosis remains a major cause of chronic respiratory morbidity in developing countries, including Indonesia. Persistent lung injury in tuberculosis is driven by chronic inflammation and cellular senescence, biological pr...
10
DOI 10.4103/ijmy.ijmy_99_26
Open DOI
Extensive Pulmonary Tuberculosis Complicated by Pyopneumothorax in a Patient with Active Celiac Disease: A Management Challenge
Tuberculosis (TB) remains a major global health concern, particularly among immunologically and nutritionally vulnerable individuals. Although celiac disease (CD) has been associated with an increased risk of TB, extensive and complicate...
Bibliographical & Catalog Notes
Print issues ceased with v. 5 (2016).
Also issued online.
Official journal of the Asian-African Society of Mycobacteriology.